Drug Profile
mRNA COVID-2019 vaccine - eTheRNA Immunotherapies
Latest Information Update: 06 Apr 2020
Price :
$50
*
At a glance
- Originator eTheRNA Immunotherapies
- Class COVID-19 vaccines; RNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical COVID 2019 infections